Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -41.82%900M | -7.78%498M | -26.65%754M | -12.43%4.52B | -3.85%1.4B | 17.02%1.55B | -57.11%540M | -8.13%1.03B | -37.61%5.16B | -26.87%1.46B |
| Net profit before non-cash adjustment | 54.95%-296M | -211.49%-1.05B | -89.19%87M | -19.91%1.69B | 150.83%602M | -212.12%-657M | 35.45%940M | 36.44%805M | -68.66%2.11B | -57.22%240M |
| Total adjustment of non-cash items | -65.44%629M | 9,510.53%1.79B | 117.83%684M | 7.07%1.83B | -152.70%-283M | 545.39%1.82B | -108.80%-19M | -53.55%314M | 175.52%1.71B | -31.33%537M |
| -Depreciation and amortization | 1.29%627M | 14.93%608M | 14.85%611M | 15.67%2.29B | 16.70%608M | 26.07%619M | 9.75%529M | 9.92%532M | 24.48%1.98B | 6.98%521M |
| -Reversal of impairment losses recognized in profit and loss | --2M | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | ---- |
| -Share of associates | 7,000.00%69M | -59.09%27M | 2,900.00%28M | 215.05%107M | 253.57%43M | 92.31%-1M | 571.43%66M | 97.37%-1M | 43.64%-93M | -203.70%-28M |
| -Disposal profit | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Net exchange gains and losses | -97.99%22M | 810.20%446M | 155.02%148M | 518.42%159M | -17,775.00%-715M | 1,004.13%1.09B | 132.24%49M | -212.55%-269M | 92.31%-38M | -109.52%-4M |
| -Other non-cash items | -184.26%-91M | 141.63%276M | -298.08%-103M | -430.88%-722M | -556.25%-219M | 244.00%108M | -563.00%-663M | 677.78%52M | 55.99%-136M | -78.76%48M |
| Changes in working capital | 47.66%567M | 36.48%-242M | 81.32%-17M | -25.62%993M | 59.20%1.08B | -15.42%384M | -209.17%-381M | 38.10%-91M | 46.70%1.34B | 4.78%679M |
| -Change in receivables | -291.67%-376M | 395.13%788M | 89.86%-73M | -576.36%-786M | 11.65%297M | 18.64%-96M | -270.83%-267M | -908.99%-720M | 173.33%165M | -42.55%266M |
| -Change in inventory | ---- | ---- | ---- | -11.45%-370M | ---- | ---- | -1,115.38%-132M | -55.49%-283M | -445.83%-332M | ---- |
| -Change in payables | 1,101.54%781M | -388.37%-868M | -91.10%56M | 43.08%2.15B | 54.90%1.15B | -83.87%65M | -26.23%301M | 1,264.81%629M | 44.56%1.5B | 737.08%745M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | -9.47%86M | -7.45%87M | -3.33%87M | 7.25%414M | 3.05%135M | -1.04%95M | 13.25%94M | 18.42%90M | 56.28%386M | 61.73%131M |
| Tax refund paid | 18.85%-155M | -43.18%-63M | -5.00%-63M | 28.37%-303M | 91.40%-8M | 18.72%-191M | -12.82%-44M | -7.14%-60M | 8.44%-423M | 70.66%-93M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -42.73%831M | -11.53%522M | -26.47%778M | -9.63%4.63B | 2.21%1.53B | 22.65%1.45B | -54.72%590M | -7.11%1.06B | -36.40%5.12B | -14.87%1.49B |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 18.87%-516M | 42.33%-312M | -16.73%-586M | -4.38%-2.45B | 24.81%-773M | -28.74%-636M | -27.00%-541M | -25.19%-502M | -24.88%-2.35B | -64.48%-1.03B |
| Net business purchase and sale | -172.50%-109M | ---37M | 20.93%-136M | 56.93%-115M | 355.26%97M | -2,100.00%-40M | --0 | ---172M | 97.60%-267M | 99.66%-38M |
| Dividends received (cash flow from investment activities) | 18.75%19M | ---- | ---- | 213.04%72M | 409.09%56M | --16M | ---- | ---- | -78.30%23M | 10.00%11M |
| Investing cash flow | 8.18%-606M | 37.71%-337M | -7.12%-722M | 3.78%-2.5B | 41.23%-620M | -37.50%-660M | 17.66%-541M | -68.08%-674M | 79.98%-2.59B | 90.99%-1.06B |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 88.10%158M | -106.25%-30M | 294.38%311M | 259.41%363M | -128.67%-41M | 4,300.00%84M | 1,330.77%480M | -15,900.00%-160M | -53.02%101M | 1,530.00%143M |
| Increase or decrease of lease financing | -87.50%-45M | -14.63%-47M | -12.50%-45M | -17.73%-166M | -32.61%-61M | 25.00%-24M | -41.38%-41M | -17.65%-40M | -110.45%-141M | -119.05%-46M |
| Cash dividends paid | 70.00%-240M | --0 | 40.00%-240M | 37.50%-1.2B | --0 | -25.00%-800M | --0 | 68.75%-400M | 50.00%-1.92B | --0 |
| Cash dividends for minorities | --0 | --0 | --0 | ---34M | ---2M | --4M | ---2M | ---34M | --0 | --0 |
| Interest paid (cash flow from financing activities) | -36.99%-100M | 39.56%-55M | -145.45%-54M | -6.51%-229M | 54.26%-43M | -217.39%-73M | -62.50%-91M | 47.62%-22M | -95.45%-215M | -308.70%-94M |
| Financing cash flow | 71.94%-227M | -138.15%-132M | 95.73%-28M | 41.79%-1.27B | -5,000.00%-147M | -16.07%-809M | 379.03%346M | 51.66%-656M | 42.85%-2.18B | 105.56%3M |
| Net cash flow | ||||||||||
| Beginning cash position | 3.17%9.71B | 6.01%9.61B | 7.10%9.93B | 4.28%9.27B | -3.60%8.74B | 3.91%9.41B | 7.61%9.06B | 4.28%9.27B | -45.77%8.89B | -52.55%9.07B |
| Current changes in cash | 88.89%-2M | -86.58%53M | 110.29%28M | 146.44%865M | 71.95%760M | -400.00%-18M | -24.33%395M | 56.06%-272M | 104.03%351M | 104.42%442M |
| Effect of exchange rate changes | 97.39%-17M | 193.88%46M | -607.35%-345M | -813.79%-207M | 277.50%426M | -16,400.00%-652M | -144.14%-49M | -55.84%68M | -97.60%29M | -12.68%-240M |
| End cash Position | 10.86%9.69B | 3.17%9.71B | 6.01%9.61B | 7.10%9.93B | 7.10%9.93B | -3.60%8.74B | 3.91%9.41B | 7.61%9.06B | 4.28%9.27B | 4.28%9.27B |
| Free cash flow | -61.35%315M | 328.57%210M | -65.65%191M | -21.43%2.17B | 62.85%754M | 18.29%815M | -94.41%49M | -24.66%556M | -55.14%2.77B | -59.03%463M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.